Review reviewHigh

CVE-2026-32905

OpenClaw OpenClaw, openclaw

OpenClaw before 2026.5.4 contains an authorization bypass vulnerability in the bundled device-pair plugin that allows non-owner authorized chat senders to issue device-pairing bootstrap codes without proper scope validation. Attackers with chat command access can create setup codes to enroll devices with operator/node capabilities, granting persistent credentials until manual removal.

CVSS
8.7
EPSS
0.24%
15.0% percentile
CISA KEV
Not listed
Published
2026.05.30
PRIORITY ASSESSMENT

Review review

The CVSS severity warrants an early asset and exposure review.

Known exploitationNot established by KEV
Exploit probability0.24%
Technical severityCVSS 8.7

Vulnerability overview

OpenClaw before 2026.5.4 contains an authorization bypass vulnerability in the bundled device-pair plugin that allows non-owner authorized chat senders to issue device-pairing bootstrap codes without proper scope validation. Attackers with chat command access can create setup codes to enroll devices with operator/node capabilities, granting persistent credentials until manual removal.

Affected product and versions

Product
OpenClaw OpenClaw, openclaw
Affected versions
< 2026.5.4
Fixed versions
2026.5.4

Recommended response sequence

Confirm exposure before applying a vendor-supported change.

Full remediation guide
  1. 1
    Identify

    Confirm that OpenClaw OpenClaw, openclaw and an affected version are present.

  2. 2
    Prioritize

    Combine exploitation signals with asset exposure and business criticality.

  3. 3
    Remediate

    Follow the vendor advisory or supported update path and preserve rollback options.

  4. 4
    Verify

    Recheck the version, service health, access paths, and relevant logs.

Technical data

CVSS vector
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
CWE
CWE-862
CVE-2026-32905 — OpenClaw OpenClaw, openclaw | SECUFOCUS NOW